Peptide Guides

Retatrutide targets three metabolic receptors — GLP-1, GIP, and glucagon — through a single molecule. This article explains how each pathway contributes to its unique research profile.

A detailed scientific breakdown of how Tirzepatide engages GIP and GLP-1 receptors simultaneously, and what this dual incretin signalling means for metabolic research.

An in-depth comparison of GIP and GLP-1 receptors, their distinct signalling roles, and why dual agonism represents a significant advance in metabolic research.

A comprehensive mechanistic overview of GLP-1 receptor agonists — how they bind, signal, and influence metabolic pathways in research settings.

A research-level review of how GLP-1, GIP, and glucagon receptor agonism affect white and brown adipose tissue biology, including adipokine secretion, lipolysis signalling, and BAT thermogenesis.

A deep dive into glucagon receptor biology and what GCGR agonism uniquely contributes to multi-target metabolic peptide research — including energy expenditure, hepatic lipid metabolism, and BAT thermogenesis.

A research-focused overview of how incretin hormones GLP-1 and GIP regulate glucose homeostasis and appetite, with mechanistic detail on their pancreatic and CNS signalling pathways.

A full mechanistic breakdown of Retatrutide’s tri-agonist activity at GLP-1, GIP, and glucagon receptors — explaining why each receptor pathway is targeted and what this means for metabolic research.

A detailed mechanistic breakdown of how Tirzepatide activates GIP and GLP-1 receptors simultaneously, and what this means for metabolic research models studying glucose regulation and appetite signalling.

An in-depth scientific comparison of GIP and GLP-1 receptor biology, exploring how dual agonism produces synergistic metabolic effects and why it matters for modern peptide research.